DatasetName,AP3D1_S(400) AP3D1_S(489) AP3D1_S(567) AP3D1_S(571) AP3D1_S(609) AP3D1_S(632) AP3D1_S(658) AP3D1_S(685) AP3D1_S(686) AP3D1_S(688) AP3D1_S(721) AP3D1_S(738) AP3D1_S(758) AP3D1_S(759) AP3D1_S(764) AP3D1_S(788) AP3D1_S(827) AP3D1_S(829) AP3D1_S(836) AP3D1_S(9) AP3D1_T(696) AP3D1_Y(633) AP3D1_Y(682) AP3D1_Y(724),AP3D1_S(463) AP3D1_S(634) AP3D1_S(636),AP3D1_S(4)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.5239526018461631,,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,0.5266768709668957,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.532687419387662,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.5325292554568108,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,0.5341483656833063,,
ZX2022_Control Replicate 2,0.5302731538521959,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5321911652085646,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5278901780527273,0.3142526409849349,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.5205104478615857,,
RB2022_5_PreEndurance,0.5295682412516601,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5165891325376071,,
WZ2023_Pu_010_30min,0.5284799128707242,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.5289216343101485,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.5272275229060099,,
RB2022_8_RecoveryEndurance,0.5327584071163765,,
KBE2022_Log2_Ex_14_U,0.5281699791420534,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5201225620785271,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,0.5352794063290095,,
PG2020_Intensity 8h_C,0.5226633679985145,,
AH2018_SILAC_MR_2_N,0.5222070398272382,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5308890915847068,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5403168999085078,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.5265730730792052,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5313893453410871,,
GF2025_P6_Sph,0.5271206192070176,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5299086650938954,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5346209940324266,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.5279770925074946,0.3168996760767227,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.534400519899962,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5303420928132255,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5331093889162647,,
AH2018_SILAC_MR_2_X,0.5282928089778094,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.5314446538730038,0.35373810394507305,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.5236666833901581,,
EJN2021_3_Rest_Basal,0.5226424714861397,,
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.5243327653710265,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,0.530495355697504,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5301957933183189,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5337637797369542,,
CK2022_11 40-1,0.5309257877038575,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.524620893257245,,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,0.5288803377603472,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.5327936674007215,0.36016814734850033,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.5330793781046473,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,0.5263151027239205,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,0.5281926807735563,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.5328142716639132,,
CK2022_1 200-1,0.5325528352486936,,
PG2020_Intensity Mock_10h_D,0.5245731876627949,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5170668089287435,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,0.5317260665680735,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5309969354455051,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5260164105678542,,
KBE2022_Log2_Ex_8_T,0.5282303585268727,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.5345791813061241,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.5373772900786299,,
CK2022_3 40-1,0.5265671483550783,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.5286536949887642,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.524920069930071,,
EJN2021_5_Rest_Basal,0.5248122374288176,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.5267645123388656,,
YA2020_Reporter_intensity_Normal_No.1,0.5269814140045904,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.5084927776740223,,
SR2019_Hs578T_Biol_repl_3,0.5281713796004993,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5275446855609595,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5321742012351415,,
HS2024_8_I_T3,,,
CF2017_EOC 3,0.5281305135477444,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,0.5295752928258054,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5324196175731998,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5274015546679988,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.5314658496100048,,
KS2014_Intensity N3,0.5231968765071747,,
RB2022_4_RecoveryEndurance,0.5335496064870356,,
RB2022_5_RecoveryEndurance,0.5316867320509017,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.5332908403249461,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,0.5306987472755639,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.5298428949092118,,
KS2014_Intensity E15_2,0.5282796407078721,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.5126541985132114,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,0.5294629105323355,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.5250040362208983,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5279939369526557,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.5280813894106106,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5231212131160244,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.5280103924534189,0.3184534641656899,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.516427190060407,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.5340567690546846,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,0.7644382702368221
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,0.5329314540182682,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.5233493100886365,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,0.5196511951389857,,
CK2022_14 40-1,0.530590336467425,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.525261944554878,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,0.5289385434445049,,
AR2021_ALG 10 μM,0.5130644562704781,0.2526268991323906,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.5269929020487557,,
EJN2021_4_Rest_Ins,0.5280799641765094,,
RN2012_H05,0.5355680536546407,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5259433215248717,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.5266994484900689,,
EJN2021_1_Rest_Ins,0.5269387975920201,,
HH2022_Reporter intensity 3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.5353685425261664,,
JW2021_After_3,,,
GF2025_P8_Sph,0.5277530479882647,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.5379861388204898,,
CK2022_12 200-1,0.540010512706504,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,0.5272867965013287,,
AH2018_TMTMS2_2_N,0.5219509278001714,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,0.7945717937251726
AH2018_TMTMS3_Pool,0.5255016870383977,,
KS2014_Intensity N4,0.5222878662029687,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.521135541708224,,
CK2022_14 200-1,0.5387441624442421,,
SR2019_Hs578T_Biol_repl_1,0.5272710346627243,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5181033112245874,,
AST2020_anti-CD3+PDL2.2,0.5279939574776223,0.31869719015335596,
PG2020_Intensity Mock_10h_A,0.5083436637424434,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5337722955075858,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.5350665103059101,,
GF2025_P1_Adh,0.5330534655944545,,
GF2025_P1_Sph,0.5295292336248224,,
EJN2021_5_Ex_Basal,0.5251154626696058,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5364442081638922,,
CF2017_EOC 1,0.5252443295058783,,
CK2022_3 200-1,0.5331989534741223,,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,0.537664532270082,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.5267114169304057,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.533004001330321,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.5304049424858204,,
AR2021_ALG 1 μM,0.5138374703924792,0.28191617573836975,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,0.5260108587199115,,
EJN2021_1_Rest_Basal,0.5270290598408247,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5235532392760812,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5302873882801419,,
CK2022_9 16-1,0.5335009822859654,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5383171162949693,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.5261734024151942,,
CK2022_16 16-1,0.5349581608619813,,
FS2019_db/db3,,,
CK2022_15 40-1,0.5315028056850081,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5253545519018528,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.5271460972159212,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.527827891877097,,
AH2018_LFQ_M_1_N,0.5270629625427706,,
KBE2022_Log2_Ex_27_U,0.5309432326891872,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.5335765443992058,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.5296367593942048,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,0.5306939172811848,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.5334863470916975,,
RN2012_L13,0.5220947603214544,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.5267326580224078,,
SR2019_SKBR3_Biol_repl_3,0.5276687251345048,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.530436241646557,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5343850664372009,,
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5132148861789124,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.5271421736232128,,
AH2018_TMTMS2_3_X,0.5242428304148594,,
GF2025_P3_Adh,0.5268128397589292,,
SR2019_JIMT1_Biol_repl_2,0.5296748464832887,,
AH2018_TMTMS2_1_C,0.5228964474523383,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5324962780689293,,
KBE2022_Log2_Ex_19_U,0.5280320292360393,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.528429904761803,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.5303559305391695,,
AST2020_Control,0.5282981830220793,0.3111170004305906,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5217071288132504,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,0.5292670590817391,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.5225524456219595,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.5219633976530833,,
HH2022_Reporter intensity 1,,,
HH2022_Reporter intensity 2,,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.5266181270195208,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5256376406249813,,
SR2019_LM2_Biol_repl_3,0.5265741888248311,,
RB2022_4_RecoveryStrength,0.530273964766251,,
CR2017_Ratio Replicate 2,0.5329770941446469,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,0.524364183367768,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5266762412562965,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.5237882887954048,,
KBE2022_Log2_Ex_9_U,0.5251013385823832,,
AH2018_SILAC_M_3_N,0.5272513397871359,,
KBE2022_Log2_Ex_13_T,0.5290003357120655,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,0.5219010272678387,,
PG2020_Intensity Mock_10h_C,0.5173463641953641,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,0.536449248883773,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.5117602143824228,,
RN2012_L12,0.5331358519020434,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.5277991066310356,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5232128816954826,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5228038254376474,,
TM2022_S2.12h.B,,,
RN2012_L15,0.5339788899292032,,
KS2014_Intensity pY_PV3,0.5342265381891252,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.5217738442144526,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.532277651973579,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.5291769067058569,,
CK2022_5 200-1,0.5279740939035553,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.5330059543708937,,
AH2018_SILAC_MR_1_X,0.5307945435899262,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.5278095830520072,,
EJN2021_5_Rest_Ins,0.5232673991453163,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,0.5327003825632656,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.5345627674657863,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.5260098379174917,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.523692812264115,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.5239159539749912,,
AH2018_SILAC_IT_2_N,0.525761547466021,,
AH2018_SILAC_IT_1_X,0.5327960360751657,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5362012658079263,,
WZ2023_Pe_025_20min,0.5340791241702707,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.527644817011602,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.5232982762179833,,
RN2012_H06,0.5354209353220262,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.5307883702023196,,
SR2019_HCC1419_Biol_repl_4,0.5272636983874776,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,0.5292575224626065,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5130461870426436,,
WZ2023_Su_025_10min,0.5280919438279202,,
AH2018_LFQ_IT_4_X,0.5243485133444826,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.5137182486474069,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5232973738541915,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5374322291416743,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.5184139184252593,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.5199813253727704,,
LY2019_P7+,0.5256871367979268,,
EP2017_Untreated R#1 normalized log2 ratio,0.5243648906581485,,
RN2012_L10,0.5343432920144103,,
PG2020_Intensity 4h_C,0.5213728990395349,,
EP2017_Mitotic R#3 normalized log2 ratio,0.520398363832031,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,0.5309714456849927,,
AH2018_SILAC_IT_2_X,0.5328637044662111,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.5262865897141414,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5403757170760781,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5397533972301986,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5219945511686651,,
GF2025_P9_Sph,0.5259119351581393,,
CK2022_6 200-1,0.5259854233094611,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5273888482942163,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.5254643134356087,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.5253760858887311,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,0.5233302444825111,,
EP2017_Untreated R#3 normalized log2 ratio,0.5389320571103131,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5291690230752849,,
KS2014_Intensity pY_C4,0.5220978413794664,,
CR2017_Ratio Replicate 3.5,0.5158988216698791,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5377082628239734,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,0.5285798313374742,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.5295346196242253,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5372702172222164,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.523206869080202,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.5286989025508348,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,0.5332773437299155,,
KBE2022_Log2_Ex_39_U,0.5289758541754995,,
EP2017_Untreated R#3 log2 ratio,0.5387203234882837,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5173465695256969,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.525897094691904,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.5341316068470692,,
CR2017_Ratio Replicate 2.3,0.5231016468540853,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5280472857154249,,
YA2020_Reporter_intensity_Normal_No.2,0.5281847848160084,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.5299805899574411,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.5307954887772199,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.5282068566039515,,
CK2022_2 16-1,0.5330677673382448,,
RAM2015_Log2 B,0.5294887135994742,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5264368912855105,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,0.5369420618150204,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.528737386160329,,
AH2018_LFQ_4_N,0.5268356923369842,,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,0.5314666900895189,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,0.5269995057152536,,
LY2019_P6+,0.5345528898204444,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5270007407113756,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.5231626584742456,,
SR2019_Hs578T_Biol_repl_4,0.527041641630498,,
RB2022_8_PreStrength,0.5278409326108413,,
KS2014_Intensity C5,0.524207156046599,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.534071017897801,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5268460345665802,,
RB2022_3_PostStrength,0.5279560021142876,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,0.5265166626590715,,
AH2018_LFQ_M_4_N,0.5305630765909767,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.5227812048070369,,
AH2018_LFQ_2_X,0.5316270268599939,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.5219380607641805,,
KS2014_Intensity E15_3,0.5304239413869629,,
GF2025_P3_Sph,0.5331000179640203,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.5325390930507313,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,0.8206387894663962
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.527438609149662,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.5331643680099325,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.5211313248680461,,
ZQ2022_N1,,,
LY2019_P6-,0.5264196649209609,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5319992175298608,,
AH2018_LFQ_3_N,0.5287347934758684,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.5139247897557705,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,0.5273342103149026,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5228552500723848,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.5279004922026714,,
SR2019_BT549_Biol_repl_2,0.5268135839374748,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.5228759361681365,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.5257880650160277,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5231680315727951,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.5297262284294172,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5357799061443983,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,0.5298944284201524,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.5248956137363686,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.5343357762496592,,
EP2017_Pervanadate R#3 log2 ratio,0.5400357012098719,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.5287468626887961,,
AH2018_LFQ_M_4_C,0.5341773053578756,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,0.5323827501333208,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.5355158926933378,,
CK2022_6 40-1,0.5205861111137199,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5265149433988722,,
LY2019_P3-,0.5266285599670022,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.5262803500705889,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5354988701193583,,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.5294221612426838,,
AST2020_Control.1,0.5281269736807265,0.3158795191311124,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.530110124432224,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5274744491887355,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5236099594638316,,
RB2022_4_PreSprint,0.5333265779806219,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.5234026294788051,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,0.5309501867559062,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5334022497093719,,
LY2019_P8+,0.5320845285488655,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5256467966451811,,
KS2014_Intensity pY_PV1,0.5288051715292986,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,0.7865860396336196
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.5322168967388726,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5291984533696638,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.5282458854017298,,
LY2019_P2-,0.5216926045534293,,
AH2018_LFQ_IT_1_X,0.5312230675806464,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.5188586760665287,,
WZ2023_Pe_005_20min,0.5334705740499708,,
AST2020_Control.2,0.5281628237544252,0.31410818910996247,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5285723735685314,,
SR2019_MCF10A_Biol_repl_4,0.5265185783773986,,
KS2014_Intensity pY_C5,0.5248553559835135,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.5284894617777373,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5345760416834234,,
AH2018_TMTMS3_3_N,0.5236265813010553,,
SR2019_HCC1419_Biol_repl_2,0.5303285473602376,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.530200123789319,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5214346642937379,,
KBE2022_Log2_Ex_36_T,0.5353399601943075,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5303823374614576,,
KS2014_Intensity C2,0.5257268174748367,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5290853183370611,,
CK2022_9 200-1,0.537078922234249,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5360903453121815,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5211900127125721,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5152230651243236,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.5255272494643412,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,0.5334114596843297,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5305838632189958,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5241700245727214,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5274105398131608,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,0.5282517366404679,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.521811656207637,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5335776169891764,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.5207944112326179,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.5299646291476415,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5353911329911741,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.5232177868209166,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.5304468932378689,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.5284367385180021,0.31844837661627984,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5326201438099495,,
KBE2022_Log2_Ex_29_U,0.5273990416389506,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.5372242421506567,,
AH2018_LFQ_IT_4_N,0.526753606220646,,
CK2022_15 200-1,0.5401643027094253,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5288187894532683,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.532908137781372,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.52644029893636,,
RN2012_H01,0.5379184972728978,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.5244538020488246,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5377282886384906,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.5298038049599142,,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.5340693073578447,,
KS2014_Intensity pY_C6,0.5262595430877032,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.5298201078835493,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.5244991688196793,,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,0.5283570892598952,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5286345212181913,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.527189185423638,,
PG2020_Intensity 6h_C,0.5222276981412738,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.5308110227111021,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5249010413535856,,
CK2022_15 16-1,0.5349911117718192,,
CK2022_3 16-1,0.5319828413184465,,
LY2019_P4-,0.5222479370316107,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,0.5359139772220497,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.5257408909251753,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5252497593729625,,
CK2022_10 16-1,0.5328487404397352,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,0.7842968260293104
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5225009192729771,,
EJN2021_2_Ex_Basal,0.5330517502613785,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.530343480019902,,
AR2021_L41 10 μM,0.5137695087995998,0.28842907451365174,
CF2017_EOC 2,0.5269777807607625,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.5333040232001993,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.529663713988262,,
ZX2022_CB treated Replicate 1,0.5279909321811601,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5204801688057101,,
AR2021_L41 1 μM,0.5114535143591905,0.3529555106707543,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5219996932622949,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5293393677792476,,
KS2014_Intensity C4,0.521217653086527,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5238343091164978,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.527483800666451,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.5284802958897091,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.5320390742309861,,
AH2018_SILAC_IT_3_C,0.535484992698331,,
WZ2023_Pu_025_10min,0.5342995096065335,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,0.529851971416143,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.5240591323515104,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5334269536390515,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,0.509712754265903,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5328517004804104,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.530494270010718,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.5307085699056641,,
AH2018_SILAC_IT_2_C,0.5336690902359854,,
CK2022_5 40-1,0.5221031904089092,,
AH2018_LFQ_3_X,0.5280155147341802,,
UK2020_UA_3,,,
LY2019_P7-,0.5339105968249479,,
GF2025_P5_Adh,0.5287996975941764,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,0.5221609825215017,,
CR2017_Ratio Replicate 2.2,0.536151216967229,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.5333770491414094,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5281313238647675,,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.5267251994117189,,
KS2014_Intensity pY_E5_1,0.5255786630118612,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.524973380879942,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.5314652826992564,,
YA2020_Reporter_intensity_Cancer_No.4,0.5322407163098974,,
KS2014_Intensity pY_E5_2,0.5277062806364475,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5329353395407529,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.5347682038999012,,
AST2020_anti-CD3+PDL2,0.5281777495611059,0.3068948103544606,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5260543083130463,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.5176654905614247,,
AH2018_TMTMS2_1_X,0.5218184252836744,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,0.5252677940128325,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5250619309077537,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.5298877031001037,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.53123501754798,,
PG2020_Intensity 10h_B,0.5200137945559681,,
AH2018_TMTMS3_1_X,0.5215870756757691,,
CF2017_FTE 14,0.5265926613915993,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.525128175561329,,
SR2019_HCC1419_Biol_repl_3,0.5274555396224844,,
KBE2022_Log2_Ex_14_T,0.527144115981086,,
EP2017_Untreated R#2 normalized log2 ratio,0.525780205654326,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5229355851374207,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5374832200188971,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
